Domestic Presence
The API and intermediate market is the most volatile and price sensitive market among the various industries. Retaining your customers in this market, especially with stiff competition from neighboring China, is indeed a remarkable achievement.
Parabolic has a history of good bonding with its customers and has to its credit long term business association with some of the well known Companies of Pharmaceutical Industry as a preferred supplier like
This is all owing to the good Quality and competitive pricing of its selected product range.
The Company has recently ventured into the realm of Sterile Cephalosporin manufacturing and the target is to fast penetrate the Indian Pharmaceutical formulator market for the same. The company shall be very shortly launching its new range of non-beta lactum products.
International Business
Parabolic has established its name in the International API and intermediate circle because of its commitment to quality at affordable prices. With in a short span, the Company has penetrated the markets in 34 countries across the globe and actively exporting to its business partners in
List of Exporting Countries
| S.No | Region | Countries |
| 1. | South East Asia | Thailand |
| Vietnam | ||
| Laos | ||
| Indonesia | ||
| Malaysia | ||
| Singapore | ||
| Hongkong | ||
| Taiwan | ||
| Philippines | ||
| Korea | ||
| China | ||
| 2. | North America | USA |
| Mexico | ||
| 3. | Latin America | Argentina |
| Colombia | ||
| Peru | ||
| Chile | ||
| Guatemala | ||
| Paraguay | ||
| Uruguay | ||
| 4. | Brazil | Brazil |
| 5. | Middle East | Iran |
| Iraq | ||
| Jordan | ||
| Syria | ||
| GCC | ||
| 6. | North Africa | Egypt |
| Egypt | ||
| 7. | Rest of Africa | Ghana |
| Uganda | ||
| Nigeria | ||
| Kenya | ||
| Sudan | ||
| Zimbabwe |
The Company’s Unit II at Panchkula is a USFDA approved manufacturing facility for supplying 6-APA to USA. Five DMF have been filed in the USA for registration and the Company’s share of Exports to Regulated markets of USA and Europe is expected to increase substantially w.e.f. FY 2010.